BRIEF published on 04/25/2024 at 08:05, 6 months 29 days ago Travis Perkins plc Reports First Quarter 2024 Earnings Construction Industry Quarterly Financial Report Revenue Decline Cost Savings Travis Perkins
PRESS RELEASE published on 04/25/2024 at 08:00, 6 months 29 days ago Travis Perkins plc - first quarter trading update for the three months to 31 March 2024 Travis Perkins plc reports Q1 2024 trading update, highlighting challenging conditions with a (3.7)% decrease in Group revenue. Efforts to address loss-making activities and cost savings ongoing Trading Update Revenue Decrease Construction Sector Q1 2024 Travis Perkins Plc
BRIEF published on 04/22/2024 at 15:30, 7 months 1 day ago Travis Perkins Holds Successful AGM with Resolutions Passed Dividend Declaration Corporate Governance AGM Shareholder Engagement Travis Perkins
PRESS RELEASE published on 04/22/2024 at 15:25, 7 months 1 day ago Travis Perkins: Results of AGM Travis Perkins plc held its successful Annual General Meeting with all resolutions passed by shareholders. Results available on the company's website Annual General Meeting Shareholders Resolutions Travis Perkins Plc Results
BRIEF published on 04/17/2024 at 10:46, 7 months 6 days ago Travis Perkins Grants Nil-Cost Share Options to PDMR PDMR Travis Perkins Restricted Share Plan Nil-cost Options Share Performance
PRESS RELEASE published on 04/17/2024 at 10:41, 7 months 6 days ago Travis Perkins: Director/PDMR Shareholding Travis Perkins announced Director/PDMR Shareholding awards in Shares under RSP. Nil-cost options awarded to PDMR Robin Miller. Options vesting conditions and performance underpins disclosed PDMR Shareholding Travis Perkins Director Restricted Share Plan
BRIEF published on 04/15/2024 at 14:57, 7 months 8 days ago Correction Issued for Travis Perkins Shareholding Announcement Market Abuse Regulation Travis Perkins Shareholding Correction Director Shares Robin Miller
PRESS RELEASE published on 04/15/2024 at 14:52, 7 months 8 days ago CORRECTION Travis Perkins: Director/PDMR Shareholding Travis Perkins plc corrects previous shareholding announcement due to inaccurate information provided. Director/PDMR Robin Miller transfers shares for tax liabilities and spouse Shareholding Travis Perkins Tax Liabilities Robin Miller Conditional Awards
BRIEF published on 04/15/2024 at 14:45, 7 months 8 days ago Travis Perkins Reports PDMR Share Purchase Market Abuse Regulation Travis Perkins BAYE Scheme Stock Transaction PDMR Share Purchase
PRESS RELEASE published on 04/15/2024 at 14:40, 7 months 8 days ago Travis Perkins: Director/PDMR Shareholding Travis Perkins Director/PDMR Shareholding notification of ordinary shares purchase by Nick Roberts under BAYE scheme as per UK Market Abuse Regulation PDMR Shareholding UK Market Abuse Regulation Travis Perkins Director
Published on 11/22/2024 at 23:55, 1 day 9 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 10 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 10 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 11 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 15 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 15 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 16 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 3 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
